National Institute on Drug Abuse-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:National Institute on Drug Abuse - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014108
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine, prescription drugs, commonly abused drugs, emerging trends, salvia, and tobacco addiction, among others. It also offers services in addiction science, drug testing, drugged driving, global health, hepatitis, comorbidity, criminal justice and drug abuse areas. The institute operates AIDS research program, international program, and intramural research program, among others. NIDA is headquartered in Bethesda, Maryland, the US.

National Institute on Drug Abuse – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Institute on Drug Abuse, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
RespireRx Pharma Enters into Research Agreement with National Institute of Drug Abuse 10
Addex Therapeutics Enters into Partnership with National Institute on Drug Abuse 11
Lightlake Therapeutics Expands Co-Developmenet Agreement With National Institute On Drug Abuse 12
National Institute on Drug Abuse and AstraZeneca Enter into Partnership 13
Lightlake Therapeutics Enters Into Co-Development Agreement With National Institute On Drug Abuse 14
Licensing Agreements 15
Opiant Pharma Enters into Licensing Agreement with Walter Reed Army Institute of Research and National Institute on Drug Abuse 15
National Institute on Drug Abuse – Key Competitors 16
National Institute on Drug Abuse – Key Employees 17
National Institute on Drug Abuse – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Government and Public Interest 19
Nov 01, 2017: Understanding Addiction in the Adolescent Mind 19
Sep 27, 2017: NIH announces centers for myalgic encephalomyelitis/chronic fatigue syndrome research 21
Sep 27, 2017: Camino Pharma Co-founder Receives $10.8 Million Grant for Development of Potential Drug for Cocaine and Nicotine Addiction 23
Sep 15, 2017: Immune System Linked to Alcohol Drinking Behaviour 24
Aug 01, 2017: Collins, King Announce $185,413 in Funding to the University of New England to Support Addiction Research 26
Jan 30, 2017: New TSRI Study Shows Early Brain Changes in Fragile X Syndrome 27
Oct 13, 2016: Scripps Florida Scientists Awarded Special Grant to Develop Memory-Altering Medication for Addiction 28
Oct 07, 2016: Researchers find novel function for old protein in work that could lead to new ways to protect brain from stroke damage 29
Aug 08, 2016: NIH Grant To Fund New Center For Systems Neurogenetics Of Addiction 30
Jul 27, 2016: Infusion of Nearly $35.4 Million in Grant Funding to Support Roswell Park Research 31
Jun 28, 2016: UAMS Receives NIH Grant for First Comprehensive Study of Synthetic Marijuana Dangers 33
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Key Facts 2
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Institute on Drug Abuse, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Institute on Drug Abuse, Deals By Therapy Area, 2011 to YTD 2017 8
National Institute on Drug Abuse, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
RespireRx Pharma Enters into Research Agreement with National Institute of Drug Abuse 10
Addex Therapeutics Enters into Partnership with National Institute on Drug Abuse 11
Lightlake Therapeutics Expands Co-Developmenet Agreement With National Institute On Drug Abuse 12
National Institute on Drug Abuse and AstraZeneca Enter into Partnership 13
Lightlake Therapeutics Enters Into Co-Development Agreement With National Institute On Drug Abuse 14
Opiant Pharma Enters into Licensing Agreement with Walter Reed Army Institute of Research and National Institute on Drug Abuse 15
National Institute on Drug Abuse, Key Competitors 16
National Institute on Drug Abuse, Key Employees 17

★海外企業調査レポート[National Institute on Drug Abuse-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Antibe Therapeutics Inc (ATE):企業の財務・戦略的SWOT分析
    Summary Antibe Therapeutics Inc (Antibe), formerly Ontario Inc, is a biotechnology company that designs and develops therapies for the treatment of pain and inflammation. The company’s lead compound ATB-346, an anti-inflammatory drug, is designed against chronic pain and inflammation. It is investig …
  • Sokolovska uhelna, pravni nastupce, A.S.:企業の戦略的SWOT分析
    Sokolovska uhelna, pravni nastupce, A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • National Shipping Company of Saudi Arabia (4030):石油・ガス:M&Aディール及び事業提携情報
    Summary National Shipping Company of Saudi Arabia (Bahri) is a joint stock shipping company, which purchases, charters and operates shipping vessels for the transportation of crude oil, liquefied petroleum gas (LPG), petrochemicals, general cargo, passengers and dry bulk. It operates a fleet of very …
  • Medovex Corp (MDVX):医療機器:M&Aディール及び事業提携情報
    Summary Medovex Corp (Medovex) is a medical device company. The company operates in designing and marketing medical devices for commercial use. It offers DenerveX device, a disposable single-use kit for the treatment of various medical applications including pain relief from chronic back pain caused …
  • EnCana Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    EnCana Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, …
  • Scotiabank Private Banking:企業の戦略・SWOT・財務分析
    Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Lincoln National Corporation:企業の戦略・SWOT・財務分析
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ARK Diagnostics Inc:企業の製品パイプライン分析
    Summary ARK Diagnostics Inc (ARK Diagnostics) is a developer, manufacturer and commercializer of in vitro diagnostic immunoassay products. The company's products include protease inhibitors, levetiracetam assay, topiramate assay, non-nucleoside reverse transcriptase inhibitors, gabapentin assay, lam …
  • PLT Health Solutions Inc:企業の戦略・SWOT・財務分析
    PLT Health Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary PLT Health Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aviva Ltd.:企業の戦略・SWOT・財務情報
    Aviva Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aviva Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Rosinter Restaurants Holding Ojsc
    Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report Summary Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Torii Pharmaceutical Co Ltd (4551):製薬・医療:M&Aディール及び事業提携情報
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • Staidson (Beijing) Biopharmaceuticals Co Ltd (300204)-製薬・医療分野:企業M&A・提携分析
    Summary Staidson (Beijing) Biopharmaceuticals Co Ltd (Staidson) focuses on the research, development and commercialization of biological protein products. The company’s product portfolio comprises Su peptide Health, an injection of mouse nerve growth factor; Shu Taiqing, Shu Wei Xin, Gliclazide, Nab …
  • FLIR Systems Inc:企業の戦略・SWOT・財務情報
    FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report Summary FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析
    Summary Cleveland BioLabs Inc (Cleveland) is a bio pharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of …
  • TransAtlantic Petroleum Ltd (TAT):企業の財務・戦略的SWOT分析
    TransAtlantic Petroleum Ltd (TAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Liberty Oilfield Services Inc (LBRT):企業の財務・戦略的SWOT分析
    Liberty Oilfield Services Inc (LBRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SPX Corp (SPXC):企業の財務・戦略的SWOT分析
    SPX Corp (SPXC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Melia Hotels International SA:企業の戦略・SWOT・財務情報
    Melia Hotels International SA - Strategy, SWOT and Corporate Finance Report Summary Melia Hotels International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Living Proof Inc-製薬・医療分野:企業M&A・提携分析
    Summary Living Proof Inc (Living Proof) is a healthcare products provider that offers hair care products. The company offers hair travel kits, dry shampoos, hair conditioner, styling treatment kits, night cap overnight perfector, pre shampoo treatment, timeless shampoo, plumping mousse, nourishing s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆